ResMed (RMD) investor Michael Farrell plans 4,991-share stock sale after option exercise
Rhea-AI Filing Summary
ResMed shareholder Michael Farrell lists a proposed sale of 4,991 shares of common stock, to be sold for cash on 08/07/2026 through Fidelity Brokerage Services LLC on the NYSE, in connection with a stock option exercise.
The disclosure also lists prior sales of 4,991 shares of common stock on each of 05/07/2026, 06/08/2026, and 07/07/2026, with aggregate sale prices of $1,037,232.61, $968,064.34, and $1,090,770.57, respectively.
Positive
- None.
Negative
- None.
Key Figures
Shares to be sold: 4,991 shares
Planned sale date: 08/07/2026
Prior sale 1 amount: $1,037,232.61
+3 more
6 metrics
Shares to be sold
4,991 shares
Common stock listed as securities to be sold on 08/07/2026
Planned sale date
08/07/2026
Date for sale of 4,991 shares of common stock
Prior sale 1 amount
$1,037,232.61
Aggregate amount for 4,991 shares sold on 05/07/2026
Prior sale 2 amount
$968,064.34
Aggregate amount for 4,991 shares sold on 06/08/2026
Prior sale 3 amount
$1,090,770.57
Aggregate amount for 4,991 shares sold on 07/07/2026
Shares sold past 3 months
14,973 shares
4,991 shares sold on each of three dates in May, June, and July 2026
Key Terms
Stock Option Exercise, Securities To Be Sold, Securities Sold During The Past 3 Months
3 terms
Stock Option Exercise financial
"Common | 08/07/2026 | Stock Option Exercise | Issuer"
A stock option exercise is the act of using a previously granted right to buy shares of a company's stock at a specific, predetermined price by paying that price and receiving the shares. It matters to investors because exercising changes who owns the shares (which can dilute existing ownership), can trigger taxable events and shift potential gains or losses, and affects voting power and the company’s outstanding share count—like turning a voucher into an actual product that becomes part of circulating supply.
Securities To Be Sold financial
"144: Securities To Be Sold Common | 08/07/2026"
Securities Sold During The Past 3 Months financial
"144: Securities Sold During The Past 3 Months Michael Farrell"
AI-generated analysis. How Rhea-AI works. Not financial advice.
FAQ
What prior ResMed (RMD) stock sales did Michael Farrell report in the last three months?
Michael Farrell reported selling 4,991 shares of ResMed common stock on 05/07/2026, 06/08/2026, and 07/07/2026, for aggregate amounts of $1,037,232.61, $968,064.34, and $1,090,770.57, respectively, over the past three months.